Export Control Compliance for Technology Companies Seeking Hong Kong Listing

The Hong Kong listing application of a PRC-headquartered artificial intelligence company was formally returned by the HKEX in Q1 2025, not on financial grounds but because its prospectus failed to demonstrate a legally compliant export control framework for its dual-use semiconductor technology. This rejection, the first of its kind under the current Listing Rules regime, has sent a clear signal to the 40+ PRC technology companies currently in the HKEX pipeline: the Listing Division is now systematically scrutinising export control compliance as a threshold listing suitability issue. The shift is driven by the expanding extraterritorial reach of the US Export Administration Regulations (EAR) and the PRC’s own 2020 Export Control Law, creating a compliance gap that listing applicants must bridge with documentary precision. For sponsors and legal counsel, the HKEX’s position is unambiguous — a generic risk factor disclosure under paragraph 27 of Appendix D1A is no longer sufficient. The Exchange expects a detailed, jurisdiction-specific compliance architecture, including internal controls, licence mapping, and end-user screening protocols, supported by a legal opinion from a recognised PRC or Hong Kong law firm.

The Regulatory Architecture Governing Technology Transfers

The compliance burden for a PRC technology company listing in Hong Kong is not singular but dual-layered, requiring simultaneous adherence to both the PRC Export Control Law (promulgated 17 October 2020, effective 1 December 2020) and the US EAR (15 CFR Parts 730-774). The HKEX, through its Listing Rules Chapter 2 — which requires an issuer’s business to be “suitable for listing” — has increasingly interpreted this dual compliance as a prerequisite for admission.

PRC Export Control Law and the Control List System

The PRC Export Control Law establishes a control list system covering dual-use items, military products, and nuclear-related goods. Under Article 12 of the law, exporters must obtain a licence from the Ministry of Commerce (MOFCOM) for any item on the control list. For technology companies, the critical categories are integrated circuits, certain semiconductor manufacturing equipment, and specific AI algorithms designated as “controlled items” under the 2023 revision of the Catalogue of Technologies Prohibited or Restricted from Export.

Data from MOFCOM’s 2024 annual report indicates that the number of export licence applications for dual-use technology items increased by 34% year-on-year to 2,847, with a rejection rate of 8.2%. For a listing applicant, the HKEX’s Listing Division will request a schedule of all licences held, pending applications, and any rejection history. Where a company’s core technology falls within the restricted category, the sponsor must demonstrate that no licence is required — typically through a negative-list legal opinion from a PRC law firm with MOFCOM practice credentials.

US EAR and the Entity List Implications

The US EAR applies extraterritorially to any item that is of US origin or contains more than a de minimis threshold of US-origin content — typically 25% for most destinations, but 0% for Entity List entities under the 2022 Foreign Direct Product Rule. For a PRC technology company with supply chain exposure to US-origin EDA tools, semiconductor IP cores, or manufacturing equipment, the EAR compliance burden is material.

The HKEX’s Listing Decision LD138-2024 explicitly references the Entity List as a material risk factor. Where a company’s ultimate beneficial owners, key suppliers, or significant customers appear on the Entity List, the sponsor must disclose the specific US BIS (Bureau of Industry and Security) licence status. As of 31 December 2024, the Entity List contained 839 PRC entities, up from 612 in 2021 — a 37% increase in three years. For a listing applicant, a single Entity List-linked supply chain relationship can trigger a suitability review under Listing Rule 8.04.

Specific Compliance Areas the HKEX Scrutinises

The HKEX’s Listing Division does not operate a published checklist for export control compliance, but analysis of recent return letters and listing decisions reveals five discrete areas of focus. Each must be addressed in the prospectus and supported by sponsor due diligence.

End-User and End-Use Screening Protocols

The HKEX expects the issuer to maintain a documented end-user screening process that aligns with both PRC and US regulatory requirements. Under the PRC Export Control Law, Article 14 requires exporters to verify the end-user’s identity and confirm that the item will not be used for weapons of mass destruction or military purposes. The US EAR, under Part 744, imposes similar end-use controls for items destined to military end-users in Country Group D:5, which includes the PRC.

For a technology company whose products are sold to PRC state-owned enterprises or military-affiliated entities, the sponsor must produce evidence of a screening workflow. This typically includes a standard operating procedure (SOP) document, training records for sales and compliance staff, and a log of rejected transactions. The HKEX’s Listing Decision LD142-2024, concerning a semiconductor equipment manufacturer, required the issuer to disclose the number of transactions reviewed, the percentage rejected, and the legal basis for each rejection. The issuer reported a 2.1% rejection rate over the three-year track record period, based on 14,382 transaction reviews.

Technology Transfer and Licence Mapping

Where a company licenses technology from a US, EU, or Japanese entity, the HKEX will require a full licence chain analysis. This includes the original licence agreement, any sub-licensing permissions, and the export control classification number (ECCN) for each licensed technology. Under the US EAR, items classified under ECCN 3A001 (integrated circuits) or 3D001 (software for semiconductor development) require a licence for export to the PRC in most cases.

The sponsor must confirm that the licensed technology is not being used in the issuer’s own products without a valid US export licence. One recent case, a PRC AI chip designer, was required to obtain a legal opinion from a US law firm confirming that its internally developed neural network architecture did not incorporate any US-origin ECCN 4A003 (digital computers) technology. The legal opinion cost the issuer approximately USD 180,000 and took 14 weeks to complete — a timeline that directly impacted the listing timetable.

Internal Control Systems and the Sponsor’s Verification Burden

The HKEX’s Listing Rule 3A.02 requires a sponsor to exercise reasonable due diligence. For export control, this means the sponsor must verify the issuer’s internal control system against a recognised framework. The most commonly referenced standard is the US Department of Commerce’s “Best Practices for Compliance with the Export Administration Regulations” (published 16 August 2023), which outlines nine elements of an effective compliance programme, including management commitment, risk assessment, training, and auditing.

The sponsor must document its verification of each element. For a PRC company, this often involves a site visit to review physical security measures for controlled technology, interview compliance personnel, and test the transaction screening software. One sponsor firm reported to this publication that its export control due diligence for a recent listing consumed 380 hours of staff time, representing approximately 8% of the total sponsor work hours for the engagement.

Practical Steps for the Listing Timetable

Integrating export control compliance into a Hong Kong listing timetable requires advance planning, typically beginning 12 to 18 months before the expected A1 filing date. The following steps are based on the experience of issuers that have successfully navigated the HKEX’s scrutiny.

Phase One: Compliance Gap Analysis (Month -18 to -12)

The issuer should commission a compliance gap analysis from a law firm with both PRC and US export control expertise. The analysis should cover the full product and technology portfolio, supply chain, customer base, and licence status. The deliverable is a gap report that identifies any unlicensed technology transfers, missing end-user screening procedures, or Entity List exposures.

The cost for a comprehensive gap analysis for a mid-sized technology company (HKD 500 million to HKD 2 billion revenue) ranges from HKD 800,000 to HKD 1.5 million, depending on the number of product lines and jurisdictions. The analysis typically takes 8 to 12 weeks.

Phase Two: Remediation and Documentation (Month -12 to -6)

Where gaps are identified, the issuer must implement remediation measures. This includes applying for any required MOFCOM or US BIS licences, updating internal SOPs, and training staff. The remediation must be documented in a compliance manual that will form part of the prospectus disclosure.

A critical step is obtaining a legal opinion from a PRC law firm confirming that the issuer’s technology does not fall within the restricted categories under the PRC Export Control Law. The opinion should cite specific catalogue numbers and explain why each technology is excluded. A parallel US legal opinion is required where US-origin technology is involved.

Phase Three: Sponsor Due Diligence and Prospectus Disclosure (Month -6 to 0)

The sponsor will incorporate the compliance documentation into its due diligence report. The prospectus should include a dedicated section under “Regulatory Compliance” that describes the export control framework, lists all licences held, and discloses any pending or rejected applications. The HKEX’s Listing Decision LD145-2024 specifies that the disclosure must be “sufficiently detailed to enable a reasonable investor to assess the materiality of the export control risk.”

The issuer should also prepare for Listing Division follow-up questions. Common queries include: (i) the legal basis for concluding that a specific technology is not controlled; (ii) the percentage of revenue derived from products incorporating US-origin technology; and (iii) the contingency plan if a key export licence is revoked. The response time for these queries is typically 10 to 15 business days, and failure to respond comprehensively can result in a return of the application.

Actionable Takeaways for Issuers and Sponsors

1. Commission a dual-jurisdiction compliance gap analysis at least 18 months before the planned A1 filing, covering both the PRC Export Control Law and the US EAR, to identify unlicensed technology transfers and Entity List exposures before they become listing impediments.

2. Obtain separate legal opinions from a recognised PRC law firm and a US law firm confirming the export control classification of all core technologies, with specific ECCN and catalogue references, as these opinions will form the backbone of the prospectus disclosure.

3. Implement a documented end-user screening SOP with a transaction review log that records the legal basis for each acceptance or rejection, as the HKEX’s Listing Division will request this data for the entire three-year track record period.

4. Budget a minimum of HKD 2.5 million for export control compliance costs, including legal opinions, licence applications, and sponsor due diligence time, and factor a 12- to 16-week remediation window into the listing timetable.

5. Prepare a contingency disclosure in the prospectus that addresses the specific risk of a US BIS Entity List designation or a MOFCOM licence revocation, including the estimated financial impact and the operational response plan.